Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.2.707

A Logistic Model Including Risk Factors for Lymph Node Metastasis Can Improve the Accuracy of Magnetic Resonance Imaging Diagnosis of Rectal Cancer  

Ogawa, Shimpei (Department of Surgery II, Tokyo Women's Medical University School of Medicine)
Itabashi, Michio (Department of Surgery II, Tokyo Women's Medical University School of Medicine)
Hirosawa, Tomoichiro (Department of Surgery II, Tokyo Women's Medical University School of Medicine)
Hashimoto, Takuzo (Department of Surgery II, Tokyo Women's Medical University School of Medicine)
Bamba, Yoshiko (Department of Surgery II, Tokyo Women's Medical University School of Medicine)
Kameoka, Shingo (Department of Surgery II, Tokyo Women's Medical University School of Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.2, 2015 , pp. 707-712 More about this Journal
Abstract
Background: To evaluate use of magnetic resonance imaging (MRI) and a logistic model including risk factors for lymph node metastasis for improved diagnosis. Materials and Methods: The subjects were 176 patients with rectal cancer who underwent preoperative MRI. The longest lymph node diameter was measured and a cut-off value for positive lymph node metastasis was established based on a receiver operating characteristic (ROC) curve. A logistic model was constructed based on MRI findings and risk factors for lymph node metastasis extracted from logistic-regression analysis. The diagnostic capabilities of MRI alone and those of the logistic model were compared using the area under the curve (AUC) of the ROC curve. Results: The cut-off value was a diameter of 5.47 mm. Diagnosis using MRI had an accuracy of 65.9%, sensitivity 73.5%, specificity 61.3%, positive predictive value (PPV) 62.9%, and negative predictive value (NPV) 72.2% [AUC: 0.6739 (95%CI: 0.6016-0.7388)]. Age (<59) (p=0.0163), pT (T3+T4) (p=0.0001), and BMI (<23.5) (p=0.0003) were extracted as independent risk factors for lymph node metastasis. Diagnosis using MRI with the logistic model had an accuracy of 75.0%, sensitivity 72.3%, specificity 77.4%, PPV 74.1%, and NPV 75.8% [AUC: 0.7853 (95%CI: 0.7098-0.8454)], showing a significantly improved diagnostic capacity using the logistic model (p=0.0002). Conclusions: A logistic model including risk factors for lymph node metastasis can improve the accuracy of MRI diagnosis of rectal cancer.
Keywords
Rectal cancer; perirectal lymph nodes; lymph node metastasis; magnetic resonance imaging (MRI);
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Akasu T, Iinuma G, Takawa M, et al (2009). Accuracy of highresolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol, 16, 2787-94.   DOI
2 Al-Sukhni E, Milot L, Fruitman M, et al (2012). Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol, 19, 2212-23.   DOI
3 Beets-Tan RG, Beets GL (2011). Local staging of rectal cancer: a review of imaging. J Magn Reson Imaging, 33, 1012-9.   DOI
4 Bipat S, Glas AS, Slors FJ, et al (2004). Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology, 232, 773-83.   DOI
5 Brown G, Richards CJ, Bourne MW, et al (2003). Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology, 227, 371-7.   DOI
6 Chang HC, Huang SC, Chen JS, et al (2012). Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol, 19, 2477-84.   DOI   ScienceOn
7 Colombo PE, Patani N, Bibeau F, et al (2011). Clinical impact of lymph node status in rectal cancer. Surg Oncol, 20, 227-33.   DOI
8 Dou X, Wang RB, Yan HJ, et al (2013). Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev, 14, 3881-5.   DOI   ScienceOn
9 Gao C, Li JT, Fang L, et al (2013). Pre-operative predictive factors for intra-operative pathological lymph node metastasis in rectal cancers. Asian Pac J Cancer Prev, 14, 6293-9.   DOI   ScienceOn
10 Garzotto M, Hudson RG, Peters L, et al (2003). Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or=10ng/mL. Cancer, 98, 1417-22.   DOI
11 Guillem JG, Diaz-Gonzalez JA, Minsky BD, et al (2008). cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol, 26, 368-73.   DOI
12 Klessen C, Rogalla P, Taupitz M (2007). Local staging of rectal cancer: the current role of MRI. Eur Radiol, 17, 379-89.   DOI
13 Nadoshan JJ, Omranipour R, Beiki O, et al (2013). Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation. Asian Pac J Cancer Prev, 14, 3769-72.   DOI   ScienceOn
14 National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines TM), Rectal Cancer. Version 1. 2015 [cited 1 November 2014].
15 Ogawa S, Itabashi M, Hirosawa T, et al (2014). Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI. J Surg Oncol, 109, 227-33.   DOI
16 Peeters KC, van de Velde CJ, Leer JW, et al (2005). Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol, 23, 6199-206.   DOI
17 Quadros CA, Falcao MF, Carvalho ME, Ladeia PA, Lopes A (2012). Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma. J Surg Oncol, 106, 653-8.   DOI
18 Raghunathan G, Mortele KJ (2009). Magnetic resonance imaging of anorectal neoplasms. Clin Gastroenterol Hepatol, 7, 379-88.   DOI
19 Saraste D, Gunnarsson U, Janson M (2013). Predicting lymph node metastases in early rectal cancer. Eur J Cancer, 49, 1104-8.   DOI   ScienceOn
20 Sauer R, Becker H, Hohenberger W, et al (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351, 1731-40.   DOI
21 Schmoll HJ, Van Cutsem E, Stein A, et al (2012). ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol, 23, 2479-516.   DOI   ScienceOn
22 Stiekema A, Lok CA, Kenter GG, et al (2014). A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer. Gynecol Oncol, 132, 573-7.   DOI
23 Wang TB, Wang J, Wei XQ, Wei B, Dong WG (2012). Serum vascular endothelial growth factor-C combined with multidetector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer. Asia Pac J Clin Oncol, 8, 180-6.   DOI
24 Watanabe T, Itabashi M, Shimada Y, et al (2012). Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol, 17, 1-29.   DOI
25 White R, Ung KA, Mathlum M (2013). Accuracy of magnetic resonance imaging in the pre-operative staging of rectal adenocarcinoma: Experience from a regional Australian cancer center. Asia Pac J Clin Oncol, 9, 318-23.   DOI
26 Xie F, Yang H, Wang S, et al (2012). A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients. Sensors, 12, 9936-50.   DOI